In episode 452, James and Mike go over 2 recent publications which encapsulate all the important evidence around type 2 diabetes. We talk about the misdirection that occurs with T2DM evidence versus what we do in practice. We now have all the evidence and we know what these medications do or don’t do to important clinical endpoints. Could we please use this information when we treat T2DM.
1) Comparative Effectiveness of Glucose-Lowering Drugs for
Type 2 Diabetes – A Systematic Review and Network Meta-analysis
2) Association of glucose-lowering medications with cardiovascular outcomes: an umbrella review and evidence map